NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details Farhat Nasim12 Feb 2025 8:31 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs,...
Indian Pharma Market Sees 8.7% Growth in January 2025, But Vaccines, Ophthalmology Struggle Farhat Nasim10 Feb 2025 6:47 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) recorded an 8.7% year-on-year (YoY) growth in January 2025, reaching a monthly value of Rs 19,238...
Cipla gets VAI status for Virgonagar facility Ruchika Sharma8 Feb 2025 1:30 PM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the Company’s manufacturing...
Cipla to invest ZAR 900 million in equity share capital of South Africa subsidiary Ruchika Sharma4 Feb 2025 12:30 PM ISTMumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary...
Cipla elevates Achin Gupta as new Global Chief Operating Officer Ruchika Sharma29 Jan 2025 1:16 PM ISTMumbai: Cipla has announced the appointment of Achin Gupta, Chief Executive Officer - One India Business (SMP) as the Global Chief Operating Officer...
84 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert Susmita Roy26 Jan 2025 6:00 PM ISTNew Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control...
Cipla Global Chief Manufacturing Officer Rajeev Kumar Sinha resigns Ruchika Sharma24 Jan 2025 11:30 AM ISTMumbai: Cipla has announced that Rajeev Kumar Sinha, Global Chief Manufacturing Officer and Senior Management Personnel of the Company has...
Cipla Goa facility gets one USFDA observation Ruchika Sharma21 Jan 2025 11:30 AM ISTMumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the manufacturing...
Cipla hit with over Rs 9 crore GST penalty, plans appeal Ruchika Sharma18 Jan 2025 3:20 PM ISTDrug major Cipla has been hit with a penalty of Rs 9.77 crore by the GST Authority for alleged tax violations under the Central Goods and Services Tax...
Indian Pharma Market reaches Rs 19,083 crore in December, Check out top performing brands Farhat Nasim16 Jan 2025 7:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This...
Cipla's Azithromycin Price Battle: NPPA Increases Ceiling with New Revision Farhat Nasim13 Jan 2025 5:50 PM ISTNew Delhi: In a major win for Cipla Ltd., the National Pharmaceutical Pricing Authority (NPPA) has issued a revised calculation sheet for the ceiling...
Indian Pharma Market Reached Rs 2,21,425 Crore in 2024: PharmaTrac Farhat Nasim8 Jan 2025 3:59 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) witnessed significant progress in December 2024, registering a 7.7% growth in value and a 1.1%...
